Combining pooled cancer-associated network pharmacology with co-crystallized ligand benchmarking suggests that CBD may exert its biological activity through coordinated modulation of multiple cancer-related signaling pathways rather than a single molecular target.
Marlon C. Mallillin, A. Chattopadhyay, Irish Mhel C. Mitra et al.· Journal of Phytomedicine· 0 citations
Current evidence is limited by small, mainly single-dose studies, predominantly Chinese populations, and the absence of validated exposure-response relationships integrating imrecoxib, M1, and M2, and the absence of validated exposure-response relationships integrating imrecoxib, M1, and M2.
Sheng-Nan Zhao, Charlie Li, Marlon C. Mallillin et al.· Clinical Pharmacokinetics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.